CD274 and breast cancer: Taking advantage of these characteristics, an electrochemical biosensing method based on DNA amplification-responsive metal–organic frameworks (PVP@HRP@ZIF-8) for accurate identification of programmed death ligand-1 positive (PD-L1) exosomes in breast cancer has been developed (Figure 9A) [152].